{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:39:08Z","timestamp":1778499548908,"version":"3.51.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Cardiogenic shock (CS) remains one of the most critical challenges in emergency cardiology, associated with high mortality rates. Early recognition and prevention of its progression are pivotal, as preventing shock not only improves prognosis but also significantly reduces treatment costs compared with managing established shock. Stage A of the Society for Cardiovascular Angiography and Interventions classification demonstrates substantial clinical and prognostic heterogeneity in real-world practice. The criteria for stage A remain ambiguous: studies vary in defining \u201cextensive myocardial infarction,\u201d overlook the impact of infarct localization, and fail to account for microvascular dysfunction and systemic inflammation in disease progression. This results in the inclusion of patients with diametrically opposed risks\u2014from minimal to critical\u2014limiting opportunities for preventive intervention. A key issue is the lack of specific biomarkers to identify patients at genuine risk of shock progression. Emerging evidence highlights the underappreciated roles of microcirculatory disturbances and inflammatory responses. Integrating imaging techniques and inflammatory biomarkers into CS diagnostic algorithms, as supported by recent studies, represents a promising direction. Dynamic reassessment of patient status, including continuous monitoring of lactate, hemodynamics, and organ perfusion markers, is another critical aspect. Early application of mechanical circulatory support in stages A\u2013B reduces mortality but requires precise identification of the target population. Only a multidisciplinary approach incorporating dynamic risk stratification and precision methods can minimize inappropriate use of aggressive therapies or ensure their timely application, thereby improving outcomes in patients at risk of CS.<\/jats:p>","DOI":"10.1097\/crd.0000000000001027","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:00:41Z","timestamp":1756126841000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Stage A Cardiogenic Shock in the SCAI Classification: Limitations and Prospects for Diagnostic Improvement"],"prefix":"10.1097","author":[{"given":"Stanislav","family":"Dil","sequence":"first","affiliation":[{"name":"From the Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kercheva","sequence":"additional","affiliation":[{"name":"From the Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Belich","sequence":"additional","affiliation":[{"name":"From the Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Rumyantseva","sequence":"additional","affiliation":[{"name":"From the Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Krivosheev","sequence":"additional","affiliation":[{"name":"From the Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyacheslav","family":"Ryabov","sequence":"additional","affiliation":[{"name":"From the Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia"},{"name":"Siberian State Medical University, Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"R1-20250825","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R2-20250825","first-page":"359","article-title":"Clinical characteristics, management and predictors of mortality: results from national prospective cardiogenic shock registry (CZECH-SHOCK).","volume":"14","author":"Pazdernik","year":"2025","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R3-20250825","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ahj.2020.12.014","article-title":"Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock.","volume":"236","author":"Thangam","year":"2021","journal-title":"Am Heart J"},{"key":"R4-20250825","first-page":"CD013002","article-title":"Mechanical assist devices for acute cardiogenic shock.","volume":"6","author":"Ni Hici","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20250825","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2014.07.958","article-title":"National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis.","volume":"64","author":"Stretch","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250825","doi-asserted-by":"crossref","first-page":"68","DOI":"10.18087\/cardio.2022.7.n2156","article-title":"Intra-aortic balloon pump in patients with myocardial infarction and cardiogenic shock of stages A and B.","volume":"62","author":"Vyshlov","year":"2022","journal-title":"Kardiologiia"},{"key":"R7-20250825","doi-asserted-by":"crossref","first-page":"691","DOI":"10.31083\/j.rcm2203078","article-title":"Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome.","volume":"22","author":"Kaddoura","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"R8-20250825","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.3390\/jcm12226988","article-title":"Outcomes of ECLS-SHOCK eligibility criteria applied to a real-world cohort.","volume":"12","author":"von Lewinski","year":"2023","journal-title":"J Clin Med"},{"key":"R9-20250825","first-page":"666","article-title":"Epidemiology of shock in contemporary cardiac intensive care units: data from the critical care cardiology trials network registry.","volume":"73","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R10-20250825","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ahj.2020.02.018","article-title":"Admission diagnosis and mortality risk prediction in a contemporary cardiac intensive care unit population.","volume":"224","author":"Jentzer","year":"2020","journal-title":"Am Heart J"},{"key":"R11-20250825","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MAT.0000000000001933","article-title":"Prognosis of venoarterial extracorporeal membrane oxygenation in mixed, cardiogenic and septic shock.","volume":"69","author":"Kim","year":"2023","journal-title":"ASAIO J"},{"key":"R12-20250825","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock.","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med"},{"key":"R13-20250825","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1378\/chest.124.5.1885","article-title":"Do all nonsurvivors of cardiogenic shock die with a low cardiac index?","volume":"124","author":"Lim","year":"2003","journal-title":"Chest"},{"key":"R14-20250825","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.15829\/1560-4071-2023-5355","article-title":"Diagnosis and treatment of sepsis-induced cardiomyopathy using hemosorption therapy: a case report.","volume":"28","author":"Dil","year":"2023","journal-title":"Russ J Cardiol"},{"key":"R15-20250825","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/medicina61010103","article-title":"Myocardial infarction-associated shock: a comprehensive analysis of phenotypes, SCAI classification, and outcome assessment.","volume":"61","author":"Dil","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"R16-20250825","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock.","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R17-20250825","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021.","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250825","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.mayocp.2022.12.007","article-title":"Cardiogenic shock classification and associated mortality risk.","volume":"98","author":"Hill","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"R19-20250825","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R20-20250825","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jclinepi.2020.06.015","article-title":"The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.","volume":"126","author":"Minozzi","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"R22-20250825","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock.","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"R23-20250825","doi-asserted-by":"crossref","first-page":"e009714","DOI":"10.1161\/CIRCHEARTFAILURE.122.009714","article-title":"Clinician and algorithmic application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry.","volume":"16","author":"Patel","year":"2023","journal-title":"Circ Heart Fail"},{"key":"R24-20250825","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2016.11.037","article-title":"Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock.","volume":"119","author":"Basir","year":"2017","journal-title":"Am J Cardiol"},{"key":"R25-20250825","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","article-title":"A standardized and comprehensive approach to the management of cardiogenic shock.","volume":"8","author":"Tehrani","year":"2020","journal-title":"JACC Heart Fail"},{"key":"R26-20250825","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/SHK.0000000000002184","article-title":"Intra-aortic balloon pump reduces 30-day mortality in early-stage cardiogenic shock complicating acute myocardial infarction according to scai classification.","volume":"60","author":"Luo","year":"2023","journal-title":"Shock"},{"key":"R27-20250825","first-page":"E213","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock.","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R28-20250825","first-page":"E288","article-title":"SCAI cardiogenic shock classification after out of hospital cardiac arrest and association with outcome.","volume":"97","author":"Pareek","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"R29-20250825","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/CCM.0000000000004948","article-title":"The range of cardiogenic shock survival by clinical stage: data from the critical care cardiology trials network registry.","volume":"49","author":"Lawler","year":"2021","journal-title":"Crit Care Med"},{"key":"R30-20250825","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit.","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R31-20250825","doi-asserted-by":"crossref","first-page":"e006956","DOI":"10.1161\/CIRCOUTCOMES.120.006956","article-title":"Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients.","volume":"13","author":"Jentzer","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R32-20250825","doi-asserted-by":"crossref","first-page":"e0273086","DOI":"10.1371\/journal.pone.0273086","article-title":"Application of the SCAI classification to admission of patients with cardiogenic shock: analysis of a tertiary care center in a middle-income country.","volume":"17","author":"Gonz\u00e1lez-Pacheco","year":"2022","journal-title":"PLoS One"},{"key":"R33-20250825","first-page":"1339","article-title":"Prospective validation of the SCAI shock classification: single center analysis.","volume":"96","author":"Baran","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R34-20250825","doi-asserted-by":"crossref","first-page":"e032748","DOI":"10.1161\/JAHA.123.032748","article-title":"Serial assessment of shock severity in cardiac intensive care unit patients.","volume":"12","author":"Jentzer","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R35-20250825","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/jcm13072101","article-title":"Evolution of cardiogenic shock management and development of a multidisciplinary team-based approach: ten years experience of a single center.","volume":"13","author":"Belfioretti","year":"2024","journal-title":"J Clin Med"},{"key":"R36-20250825","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.21037\/cdt-24-226","article-title":"Predictive models of in-hospital deterioration of Society of Cardiovascular Angiography and Intervention shock stage in patients with acute myocardial infarction initially presenting with stable hemodynamic condition.","volume":"14","author":"Mukaida","year":"2024","journal-title":"Cardiovasc Diagn Ther"},{"key":"R37-20250825","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials.","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3 Suppl A","key":"R38-20250825","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0735-1097(00)00879-2","article-title":"Cardiogenic shock complicating acute myocardial infarction\u2014etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?","volume":"36","author":"Hochman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R39-20250825","first-page":"490","article-title":"Primary percutaneous coronary intervention for ST elevation myocardial infarction complicated by cardiogenic shock.","volume":"63","author":"Shaikh","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"R40-20250825","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R41-20250825","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00134-018-5214-9","article-title":"Management of cardiogenic shock complicating myocardial infarction.","volume":"44","author":"Mebazaa","year":"2018","journal-title":"Intensive Care Med"},{"key":"R42-20250825","doi-asserted-by":"crossref","first-page":"36","DOI":"10.29001\/2073-8552-2021-36-4-36-46","article-title":"Phenomena of microvascular myocardial injury in patients with primary ST-segment elevation myocardial infarction: prevalence and association with clinical characteristics.","volume":"37","author":"Vyshlov","year":"2022","journal-title":"Siber J Clin Exp Med"},{"key":"R43-20250825","doi-asserted-by":"crossref","first-page":"3000605231202573","DOI":"10.1177\/03000605231202573","article-title":"Mechanism of heart failure after myocardial infarction.","volume":"51","author":"Jiang","year":"2023","journal-title":"J Int Med Res"},{"key":"R44-20250825","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease.","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"R45-20250825","first-page":"59","article-title":"C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial.","volume":"14","author":"Schupp","year":"2025","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R46-20250825","doi-asserted-by":"crossref","first-page":"103013","DOI":"10.1016\/j.eclinm.2024.103013","article-title":"Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials.","volume":"79","author":"Soussi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R47-20250825","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1093\/eurheartj\/ehz783","article-title":"Molecular signature of cardiogenic shock.","volume":"41","author":"Iborra -Egea","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:00:47Z","timestamp":1756126847000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001027","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}